Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Depression: Overview01:18

Depression: Overview

1.2K
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.2K
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

1.3K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.3K
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

2.1K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
2.1K
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

1.3K
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
1.3K
Cognitive Development During Adolescence01:18

Cognitive Development During Adolescence

1.0K
During adolescence, individuals experience significant cognitive development that enhances their understanding of others' emotions and thoughts, known as cognitive empathy. This period is marked by an increased ability to adapt to others' perspectives and a more nuanced understanding of others' mental states, a skill that is foundational for social problem-solving and conflict avoidance. The development of cognitive empathy relies heavily on the theory of mind — the...
1.0K
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

2.6K
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
2.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Arctigenin as a promising anticancer agent: a comprehensive review of molecular mechanisms across major carcinomas.

Frontiers in pharmacology·2026
Same author

Adapting an Adolescent Depression Prevention Program for Pediatric Primary Care.

Academic pediatrics·2026
Same author

Care Gap: Identifying and Bridging Barriers in Primary Palliative Care.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Growth following adversity is rare: Evidence from a multi-informant longitudinal study of children and adolescents.

Journal of research in personality·2026
Same author

Geospatial Indices of Neighborhood Environment and Preadolescent Behavioral Health Screening in Primary Care.

The Journal of pediatrics·2026
Same author

RWC Update: Modern One Health Approaches to Novel Challenges in Infectious Uveitis-Parasitic, Fungal and Mycobacterial Uveitis (Part 2); Management of 180° Iridodialysis With Aphakia and Total Hyphema; Retinal Astrocytic Hamartoma.

Ophthalmic surgery, lasers & imaging retina·2026

Related Experiment Video

Updated: May 2, 2026

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

1.8K

Screening and managing depression in adolescents.

Jami F Young1, Michelle R Miller1, Nida Khan1

  • 1Department of Clinical Psychology, Graduate School of Applied and Professional Psychology, Rutgers University, Piscataway, NJ, USA.

Adolescent Health, Medicine and Therapeutics
|March 7, 2014
PubMed
Summary

Many adolescents face major depressive episodes. This review highlights screening tools and treatments like therapy and medication for adolescent depression, emphasizing the need for improved interventions.

Keywords:
medicationpsychotherapytreatment

More Related Videos

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

31.9K
Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

3.5K

Related Experiment Videos

Last Updated: May 2, 2026

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

1.8K
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

31.9K
Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

3.5K

Area of Science:

  • Psychiatry
  • Adolescent Health
  • Mental Health Research

Background:

  • 10-15% of adolescents experience major depressive episodes.
  • Risk factors include family history, female gender, and stressful life events.
  • Many depressed adolescents remain undetected and untreated despite available interventions.

Purpose of the Study:

  • To review screening measures for identifying adolescents with elevated depression symptoms.
  • To outline efficacious treatment options for diagnosed depressive disorders.
  • To guide health professionals in selecting appropriate treatments.

Main Methods:

  • Review of existing literature on adolescent depression screening.
  • Analysis of research supporting pharmacotherapy, cognitive behavior therapy, and interpersonal psychotherapy.
  • Synthesis of recommendations for treatment selection.

Main Results:

  • Several screening measures can identify adolescents needing further evaluation.
  • Pharmacotherapy, CBT, and IPT are effective treatments for many.
  • Approximately one-third of adolescents do not fully recover after treatment.

Conclusions:

  • Effective screening and treatment options exist for adolescent depression.
  • Further research is crucial to enhance current treatments and develop novel approaches.
  • Improving detection and treatment outcomes for adolescent depression remains a priority.